首页> 外文期刊>British Journal of Radiology >X-ray dose and associated risks from radiofrequency catheter ablation procedures.
【24h】

X-ray dose and associated risks from radiofrequency catheter ablation procedures.

机译:X射线剂量和射频导管消融手术的相关风险。

获取原文
获取原文并翻译 | 示例
           

摘要

The objectives of this study were to quantify the ionizing radiation exposure to patient and operator during radiofrequency (RF) catheter ablation and to estimate the risks associated with this exposure. The study consisted of 50 RF ablation procedures, all performed in the same electrophysiology laboratory. Occupational dose to two cardiologists who performed the procedures was measured using film badges and extremity thermoluminescent dosemeters (TLDs). Absorbed dose to the patients' skin was measured using TLDs. Dose-area product (DAP) was also measured. The effective dose to the cardiologists was less than 0.15 mSv per month. The mean equivalent dose to the cardiologists' left hand and forehead was 0.24 mSv and 0.05 mSv, respectively, per RF ablation procedure, which was more than twice the mean dose for the other cardiology procedures carried out in the centre. Yearly occupational dose to the cardiologists was much lower than the relevant statutory dose limits. The mean skin dose, fluoroscopy time and DAP to patients were 0.81 Gy, 67 min and 123 Gycm(2), respectively, with a maximum of 3.2 Gy, 164 minutes and 430 Gycm(2), respectively. Mean effective dose to patients was 17 mSv, from which the excess risk of developing fatal cancer is 0.1%. Six of the patients (12%) received a skin dose above the threshold dose for radiation skin injury (2 Gy), but no skin injuries were reported. Patient skin dose and DAP were closely correlated and this allows DAP to be used to monitor patient skin dose in real-time. DAP levels were locally adopted as diagnostic reference levels (DRLs) that provide an indication during a procedure that a patient is at risk of suffering deterministic skin injury.
机译:这项研究的目的是量化射频(RF)导管消融期间对患者和操作员的电离辐射暴露,并估计与该暴露相关的风险。该研究由50个射频消融程序组成,所有程序均在同一电生理实验室中进行。使用胶片徽章和四肢热发光剂量计(TLD)测量执行该程序的两名心脏病专家的职业剂量。使用TLD测​​量患者皮肤的吸收剂量。还测量了剂量面积积(DAP)。心脏病专家的有效剂量每月少于0.15 mSv。每次射频消融手术,心脏病专家左手和前额的平均等效剂量分别为0.24 mSv和0.05 mSv,这是该中心进行的其他心脏病学手术的平均剂量的两倍以上。心脏病专家的年度职业剂量远低于相关的法定剂量限值。患者的平均皮肤剂量,透视时间和DAP分别为0.81 Gy,67分钟和123 Gycm(2),最大分别为3.2 Gy,164分钟和430 Gycm(2)。对患者的平均有效剂量为17 mSv,由此可导致致命癌症的额外风险为0.1%。其中六名患者(12%)接受的皮肤剂量高于放射性皮肤损伤的阈值剂量(2 Gy),但没有皮肤损伤的报道。患者皮肤剂量与DAP密切相关,这使得DAP可用于实时监控患者皮肤剂量。 DAP水平在当地被用作诊断参考水平(DRL),可在手术过程中指示患者有遭受确定性皮肤损伤的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号